1. Home
  2. NDSN vs EXAS Comparison

NDSN vs EXAS Comparison

Compare NDSN & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nordson Corporation

NDSN

Nordson Corporation

HOLD

Current Price

$238.15

Market Cap

12.9B

Sector

Industrials

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.16

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NDSN
EXAS
Founded
1935
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
11.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NDSN
EXAS
Price
$238.15
$101.16
Analyst Decision
Strong Buy
Buy
Analyst Count
6
20
Target Price
$265.33
$76.38
AVG Volume (30 Days)
302.3K
10.1M
Earning Date
12-10-2025
11-03-2025
Dividend Yield
1.38%
N/A
EPS Growth
N/A
N/A
EPS
7.95
N/A
Revenue
$2,784,349,000.00
$3,082,033,000.00
Revenue This Year
$6.21
$19.40
Revenue Next Year
$4.45
$13.51
P/E Ratio
$29.92
N/A
Revenue Growth
4.49
14.47
52 Week Low
$165.03
$38.81
52 Week High
$259.13
$101.87

Technical Indicators

Market Signals
Indicator
NDSN
EXAS
Relative Strength Index (RSI) 58.49 90.08
Support Level $233.14 $101.10
Resistance Level $240.18 $101.43
Average True Range (ATR) 4.35 2.43
MACD 0.61 0.97
Stochastic Oscillator 84.11 97.99

Price Performance

Historical Comparison
NDSN
EXAS

About NDSN Nordson Corporation

Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.7 billion in revenue in its fiscal 2024.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: